These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1281054)

  • 1. Epidermal proliferation and keratinization following standardized elicitation with diphenylcyclopropenone.
    van der Steen PH; van Baar HM; Boezeman JB; van Erp PE; van Vlijmen IM; van de Kerkhof PC
    Clin Exp Dermatol; 1992 Sep; 17(5):316-20. PubMed ID: 1281054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical application of dithranol on normal skin induces epidermal hyperproliferation and increased Ks8.12 binding.
    de Zwart AJ; de Jong EM; van de Kerkhof PC
    Skin Pharmacol; 1992; 5(1):34-40. PubMed ID: 1374264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine mRNA levels in Alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone.
    Hoffmann R; Wenzel E; Huth A; van der Steen P; Schäufele M; Henninger HP; Happle R
    J Invest Dermatol; 1994 Oct; 103(4):530-3. PubMed ID: 7930677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fexofenadine, an H1-receptor antagonist, partially but rapidly inhibits the itch of contact dermatitis induced by diphenylcyclopropenone in patients with alopecia areata.
    Katagiri K; Arakawa S; Hatano Y; Fujiwara S
    J Dermatol; 2006 Feb; 33(2):75-9. PubMed ID: 16556272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T-cell subsets in chronic plaque psoriasis.
    Vissers WH; Berends M; Muys L; van Erp PE; de Jong EM; van de Kerkhof PC
    Exp Dermatol; 2004 Feb; 13(2):106-12. PubMed ID: 15009104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inter-relation between inflammation and epidermal proliferation in normal skin following epicutaneous application of leukotriene-B4--an immunohistochemical study.
    de Jong EM; van Erp PE; van Vlijmen IM; van de Kerkhof PC
    Clin Exp Dermatol; 1992 Nov; 17(6):413-20. PubMed ID: 1336720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible advantage of imiquimod and diphenylcyclopropenone combined treatment versus diphenylcyclopropenone alone: An observational study of nonresponder patients with alopecia areata.
    Wasyłyszyn T; Borowska K
    Australas J Dermatol; 2017 Aug; 58(3):219-223. PubMed ID: 27087586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diphenylcyclopropenone treatment of alopecia areata induces apoptosis of perifollicular lymphocytes.
    Herbst V; Zöller M; Kissling S; Wenzel E; Stutz N; Freyschmidt-Paul P
    Eur J Dermatol; 2006; 16(5):537-42. PubMed ID: 17101475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of acute, low-dose UVB radiation on the induction of contact hypersensitivity to diphenylcyclopropenone in man.
    Friedli A; Hunziker T; Finkel B; Braathen LR
    Arch Dermatol Res; 1993; 285(1-2):1-5. PubMed ID: 7682397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of alopecia areata with diphenylcyclopropenone.
    van der Steen PH; van Baar HM; Perret CM; Happle R
    J Am Acad Dermatol; 1991 Feb; 24(2 Pt 1):253-7. PubMed ID: 2007671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Langerhans cells that express matrix metalloproteinase 9 increase in human dermis during sensitization to diphenylcyclopropenone in patients with alopecia areata.
    Heffler LC; Kastman AL; Jacobsson Ekman G; Scheynius A; Fransson J
    Br J Dermatol; 2002 Aug; 147(2):222-9. PubMed ID: 12174091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of tacalcitol (1,24(OH)2D3) on cutaneous inflammation, epidermal proliferation and keratinization in psoriasis: a placebo-controlled, double-blind study.
    Gerritsen MJ; Boezeman JB; van Vlijmen-Willems IM; Van de Kerkhof PC
    Br J Dermatol; 1994 Jul; 131(1):57-63. PubMed ID: 7519032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical immunotherapy with diphenylcyclopropenone of patients with alopecia areata--a large retrospective study on 142 patients with a self-controlled design.
    Ohlmeier MC; Traupe H; Luger TA; Böhm M
    J Eur Acad Dermatol Venereol; 2012 Apr; 26(4):503-7. PubMed ID: 21569118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of alopecia areata with diphenylcyclopropenone].
    Kietzmann H; Hardung H; Christophers E
    Hautarzt; 1985 Jun; 36(6):331-5. PubMed ID: 3160683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal conditions of spinal cord in dermatitis are improved by olopatadine.
    Hamada R; Seike M; Kamijima R; Ikeda M; Kodama H; Ohtsu H
    Eur J Pharmacol; 2006 Oct; 547(1-3):45-51. PubMed ID: 16934247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STUDIES ON STABILITY OF 2,3-DIPHENYLCYCLOPROPENONE IN CONTACT WITH WATER AND AQUEOUS NaCI SOLUTIONS. CONCLUSIONS FOR PURPOSE OF TOPICAL THERAPY OF PATIENTS WITH ALOPECIA AREATA.
    Wasylyszyn T; Borowska K
    Acta Pol Pharm; 2016 Nov; 73(6):1455-1460. PubMed ID: 29634098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
    Bovenschen HJ; Seyger MM; Van de Kerkhof PC
    Br J Dermatol; 2005 Jul; 153(1):72-8. PubMed ID: 16029329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population.
    Aghaei S
    BMC Dermatol; 2005 May; 5():6. PubMed ID: 15918897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High and low doses of haptens dictate whether dermal or epidermal antigen-presenting cells promote contact hypersensitivity.
    Bacci S; Alard P; Dai R; Nakamura T; Streilein JW
    Eur J Immunol; 1997 Feb; 27(2):442-8. PubMed ID: 9045915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical immunotherapy for alopecia areata: re-evaluation of 139 cases after an additional follow-up period of 19 months.
    van der Steen PH; Boezeman JB; Happle R
    Dermatology; 1992; 184(3):198-201. PubMed ID: 1392112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.